JUBILANT INGREVIA LIMITED (JUBLINGREA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality stand…

JUBLINGREAUpdated 6 Sept 2026, 2:47

Jubilant Ingrevia Limited

Market Cap

₹10,836Cr.

Current Price

₹680

High / Low

₹795/535

Stock P/E

31.4

ROE11.0%
ROCE12.4%
Book Value₹166
Face Value₹1.00
Dividend Yield0.73%

About

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days2624440525361
Inventory Days49097127132141116
Days Payable649101117129139139
Cash Conversion Cycle1034050555538
Working Capital Days1793223121810
ROCE %7%30%16%11%13%12%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 6 September 2026 at 2:47


Designed & Shipped by Harshit Bansal